Armando Stabile, MD

Vita-Salute San Raffaele University

Presentation(s):

• MP23-10: Are men with low risk prostate cancer but high PIRADS score lesions at mpMRI still candidate for active surveillance? Resuts from a large, multi-institutional radical prostatectomy series

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP56-06: Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP56-12: Age and Gleason Score upgrading between prostate biopsy and radical prostatectomy. Is this still true in the MRI era?

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP56-13: The percentage of positive MRI targeted biopsy cores is inversely associated with Gleason score upgrading at radical prostatectomy. The importance of accurate targeted sampling

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP70-08: Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes?

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• MP75-20: The rate of PIRADS 3 is not a proxy of the quality of MRI of the prostate. Results of a single high volume radiologist series

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• PD17-04: Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy

  Friday, May 15, 2020
  7:00 AM – 9:00 AM